Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday
出版年份 2021 全文链接
标题
Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday
作者
关键词
-
出版物
MOLECULES
Volume 26, Issue 4, Pages 923
出版商
MDPI AG
发表日期
2021-02-14
DOI
10.3390/molecules26040923
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical significance of chemokine receptor antagonists
- (2020) Miao Miao et al. Expert Opinion on Drug Metabolism & Toxicology
- Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study
- (2020) Min Zhang et al. Hepatology International
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review
- (2020) Raquel Scherer de Fraga et al. JOURNAL OF GASTROENTEROLOGY
- Synthesis of 4′-Substituted-2′-Deoxy-2′-α-Fluoro Nucleoside Analogs as Potential Antiviral Agents
- (2020) Mahesh Kasthuri et al. MOLECULES
- Discovery, Design, Synthesis, and Application of Nucleoside/Nucleotides
- (2020) Katherine Seley-Radtke MOLECULES
- Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)
- (2020) Keykavous Parang et al. MOLECULES
- Clinical characteristics of older and younger patients infected with SARS-CoV-2
- (2020) Zhiguo Zhou et al. Aging-US
- Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties
- (2020) Anna A. Maslova et al. MOLECULES
- Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy
- (2020) Miao Miao et al. Drug Design Development and Therapy
- Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action
- (2020) Hassan Yousefi et al. BIOCHEMICAL PHARMACOLOGY
- Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
- (2020) Zhili Wen et al. JOURNAL OF HEPATOLOGY
- Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance
- (2020) Nicole Bertoletti et al. MOLECULES
- Synthesis and Antiviral Evaluation of 3′-Fluoro-5′-norcarbocyclic Nucleoside Phosphonates Bearing Uracil and Cytosine as Potential Antiviral Agents
- (2020) Pierre-Yves Geant et al. MOLECULES
- Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues
- (2020) Georgios Papadakis et al. MOLECULES
- Novel Nucleoside Analogues as Effective Antiviral Agents for Zika Virus Infections
- (2020) Marcella Bassetto et al. MOLECULES
- Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV
- (2020) Nobuyo Higashi-Kuwata et al. JOURNAL OF HEPATOLOGY
- Novel Therapeutics for Epstein–Barr Virus
- (2019) Graciela Andrei et al. MOLECULES
- Propargylated Purine Deoxynucleosides: New Tools for Fluorescence Imaging Strategies
- (2019) Akkaladevi Venkatesham et al. MOLECULES
- New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
- (2019) Tănase et al. MOLECULES
- Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
- (2019) Yali Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Investigation of 5’-Norcarbocyclic Nucleoside Analogues as Antiprotozoal and Antibacterial Agents
- (2019) Anastasia Khandazhinskaya et al. MOLECULES
- Probing the Effects of Pyrimidine Functional Group Switches on Acyclic Fleximer Analogues for Antiviral Activity
- (2019) Mary K. Yates et al. MOLECULES
- The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
- (2018) Katherine L. Seley-Radtke et al. ANTIVIRAL RESEARCH
- Role of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infections
- (2018) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Tanovea® for the treatment of lymphoma in dogs
- (2018) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- 96 weeks treatment of tenofovir alafenamide vs . tenofovir disoproxil fumarate for hepatitis B virus infection
- (2018) Kosh Agarwal et al. JOURNAL OF HEPATOLOGY
- Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study
- (2018) Simon Ville et al. TRANSPLANT INTERNATIONAL
- No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection
- (2018) Andrea L. Cathcart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold
- (2018) Mary K. Yates et al. ANTIVIRAL RESEARCH
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
- (2016) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- C-Nucleosides To Be Revisited
- (2015) Erik De Clercq JOURNAL OF MEDICINAL CHEMISTRY
- Curious Discoveries in Antiviral Drug Development: The Role of Serendipity
- (2015) Erik De Clercq MEDICINAL RESEARCH REVIEWS
- AMD3100/CXCR4 Inhibitor
- (2015) Erik De Clercq Frontiers in Immunology
- An Odyssey in antiviral drug development—50 years at the Rega Institute: 1964–2014
- (2015) Erik De Clercq Acta Pharmaceutica Sinica B
- Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy
- (2014) Paul E. Sax et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
- (2013) Lars Petter Jordheim et al. NATURE REVIEWS DRUG DISCOVERY
- Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era
- (2012) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- A 40-Year Journey in Search of Selective Antiviral Chemotherapy*
- (2011) Erik De Clercq Annual Review of Pharmacology and Toxicology
- The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond
- (2011) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Highlights in the Discovery of Antiviral Drugs: A Personal Retrospective
- (2009) Erik De Clercq JOURNAL OF MEDICINAL CHEMISTRY
- The history of antiretrovirals: key discoveries over the past 25 years
- (2009) Erik De Clercq REVIEWS IN MEDICAL VIROLOGY
- GS-9219--A Novel Acyclic Nucleotide Analogue with Potent Antineoplastic Activity in Dogs with Spontaneous Non-Hodgkin's Lymphoma
- (2008) H. Reiser et al. CLINICAL CANCER RESEARCH
- Treatment of locally recurrent epstein–barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir
- (2008) Tomokazu Yoshizaki et al. JOURNAL OF MEDICAL VIROLOGY
- The discovery of antiviral agents: Ten different compounds, ten different stories
- (2008) Erik De Clercq MEDICINAL RESEARCH REVIEWS
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now